Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)

ClinicalTrials.gov ID: NCT02865850

Public ClinicalTrials.gov record NCT02865850. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 5:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-Dependent Chronic Kidney Disease (DD-CKD) (INNO2VATE - CORRECTION/CONVERSION)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction or maintenance treatment of anemia in participants with incident dialysis-dependent chronic kidney disease (DD-CKD).

Study identification

NCT ID
NCT02865850
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Akebia Therapeutics
Industry
Enrollment
369 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2016 (Actual)
Primary completion
Jan 31, 2020 (Actual)
Completion
Mar 30, 2020 (Actual)
Last update posted
Jul 18, 2022

2016 – 2020

United States locations

U.S. sites
54
U.S. states
18
U.S. cities
48
Facility City State ZIP Site status
Research Site Huntsville Alabama 35805 —
Research Site Mesa Arizona 85210 —
Research Site Anaheim California 92801 —
Research Site Canyon Country California 91387 —
Research Site Downey California 90240 —
Research Site Glendale California 91204 —
Research Site Granada Hills California 91344 —
Research Site La Mesa California 91942 —
Research Site Long Beach California 92886 —
Research Site Los Angeles California 90022 —
Research Site Montebello California 90640 —
Research Site Monterey Park California 91754 —
Research Site Newhall California 91321 —
Research Site #1 Northridge California 91324 —
Research Site #2 Northridge California 91324 —
Research Site Riverside California 92503 —
Research Site Riverside California 92505 —
Research Site Sacramento California 95825 —
Research Site San Diego California 92115 —
Research Site San Dimas California 91773 —
Research Site Whittier California 90603 —
Research Site Arvada Colorado 80002 —
Research Site Westminster Colorado 80031 —
Research Site Stamford Connecticut 06902 —
Research Site Coral Gables Florida 33134 —
Research Site Coral Springs Florida 33071 —
Research Site Lauderdale Lakes Florida 33313 —
Research Site Miami Florida 33125 —
Research Site Miami Florida 33150 —
Research Site Miami Beach Florida 33140 —
Research Site Winter Park Florida 32789 —
Research Site Augusta Georgia 30904 —
Research Site Columbus Georgia 31904 —
Research Site #2 Lawrenceville Georgia 30046 —
Research Site Statesboro Georgia 30458 —
Research Site Meridian Idaho 83642 —
Research Site Takoma Park Maryland 20912 —
Research Site Roseville Michigan 48066 —
Research Site Kansas City Missouri 64111 —
Research Site Albuquerque New Mexico 87109 —
Research Site Astoria New York 11102 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Philadelphia Pennsylvania 19106 —
Research Site #1 Chattanooga Tennessee 37408 —
Research Site #2 Chattanooga Tennessee 37408 —
Research Site Knoxville Tennessee 37923 —
Research Site Nashville Tennessee 37205 —
Research Site Arlington Texas 76015 —
Research Site El Paso Texas 79935 —
Research Site Houston Texas 77054 —
Research Site Houston Texas 77099 —
Research Site San Antonio Texas 78212-4740 —
Research Site San Antonio Texas 78229 —
Research Site Hampton Virginia 23666 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02865850, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 18, 2022 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02865850 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →